The glioma patients were divided into high expression group (n = 36) and low expression group (n = 44) according to the average LINC01087 expression level, and the correlation between LINC01087 expression and clinical parameters (Table 2) of glioma patients was determined. This evidence concerns the gene LINC01087 and central nervous system cancer.